SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001016169-22-000010
Filing Date
2022-02-04
Accepted
2022-02-04 19:09:04
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 wf-form5_164401972716567.html 5  
1 FORM 5 wf-form5_164401972716567.xml 5 3365
  Complete submission text file 0001016169-22-000010.txt   5121
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Issuer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O INKINE PHARMACEUTICAL COMPANY INC 425 PARK AVENUE NEW YORK NY 10022
Business Address
JACOB LEONARD S (Reporting) CIK: 0001049713 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 0630
Type: 5 | Act: 34 | File No.: 001-32302 | Film No.: 22595137